Compare CTSH & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTSH | MDLN |
|---|---|---|
| Founded | 1994 | 1966 |
| Country | United States | United States |
| Employees | N/A | 45000 |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.4B | 34.1B |
| IPO Year | 1998 | N/A |
| Metric | CTSH | MDLN |
|---|---|---|
| Price | $61.38 | $43.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 23 |
| Target Price | ★ $86.60 | $50.48 |
| AVG Volume (30 Days) | 4.5M | ★ 5.5M |
| Earning Date | 04-29-2026 | 02-25-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | ★ 1.11 | N/A |
| EPS | ★ 4.56 | N/A |
| Revenue | ★ $21,108,000,000.00 | N/A |
| Revenue This Year | $8.18 | $10.88 |
| Revenue Next Year | $5.04 | $7.69 |
| P/E Ratio | ★ $13.48 | $658.75 |
| Revenue Growth | ★ 6.95 | N/A |
| 52 Week Low | $58.84 | $38.50 |
| 52 Week High | $87.03 | $50.88 |
| Indicator | CTSH | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 41.51 | 52.91 |
| Support Level | $59.43 | $43.04 |
| Resistance Level | $63.08 | $46.90 |
| Average True Range (ATR) | 1.80 | 1.51 |
| MACD | 0.50 | 0.27 |
| Stochastic Oscillator | 50.53 | 73.87 |
Cognizant Technology Solutions is a multinational IT services provider that offers a range of consulting and business process outsourcing services. Originally founded in India, the company is headquartered in the US and serves enterprise customers spanning the financial services, healthcare, and resources industries. With most of its workforce located in India, Cognizant leverages a global delivery model that helps clients outsource their IT needs to offshore labor.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.